These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 1858691)
61. Current status of administration of medicines. Shane R Am J Health Syst Pharm; 2009 Mar; 66(5 Suppl 3):S42-8. PubMed ID: 19233971 [No Abstract] [Full Text] [Related]
62. Drugs and intravenous fluids. Neil JM; Scott W; Gove L Br Med J (Clin Res Ed); 1984 Oct; 289(6449):922. PubMed ID: 6434143 [No Abstract] [Full Text] [Related]
63. Hypodermic medication; early history. Haller JS N Y State J Med; 1981 Oct; 81(11):1671-9. PubMed ID: 7027101 [No Abstract] [Full Text] [Related]
64. Transition to standardized drug concentrations by the end of 2008. Jt Comm Perspect; 2005 Apr; 25(4):3, 5. PubMed ID: 15909771 [No Abstract] [Full Text] [Related]
65. [Plastic materials. Their part in the quality of care and in drug administration]. Postaire E Soins; 1996 Apr; (605):47-50. PubMed ID: 8716253 [No Abstract] [Full Text] [Related]
67. Dependence of time to reach steady-state on the length of dosage interval. Mehvar R Ann Pharmacother; 2008 Oct; 42(10):1518-9. PubMed ID: 18728101 [No Abstract] [Full Text] [Related]
68. Considering product features and costs in selecting a system for intermittent i.v. drug delivery. Rapp RP Am J Hosp Pharm; 1987 Nov; 44(11):2533-8. PubMed ID: 3318417 [No Abstract] [Full Text] [Related]
69. Technician assistance in switching patients from injectable to oral therapy. Krstenansky PM; Lau J Am J Hosp Pharm; 1994 Feb; 51(3):384-6. PubMed ID: 8160694 [No Abstract] [Full Text] [Related]
70. Letter: Volume of syringe-needle dead space. Feingold A; Walther P Am J Hosp Pharm; 1976 Aug; 33(8):756-9. PubMed ID: 949057 [No Abstract] [Full Text] [Related]
72. Drugs and intravenous fluids. Breckenridge A; Woolfson AM Br Med J (Clin Res Ed); 1984 Sep; 289(6446):637-8. PubMed ID: 6434018 [No Abstract] [Full Text] [Related]
73. Minimization of the preanalytical error in pharmacokinetic analyses and therapeutic drug monitoring: focus on IV drug administration. Kontny NE; Boos J; Würthwein G; Hempel G; Boddy AV; Groll AH; Krischke M Ther Drug Monit; 2012 Aug; 34(4):460-6. PubMed ID: 22660605 [TBL] [Abstract][Full Text] [Related]
76. Visual compatibility of premixed theophylline or heparin with selected drugs for i.v. administration. Kershaw BP; Monnier HL; Mason JH Am J Hosp Pharm; 1993 Jul; 50(7):1360, 1362-3. PubMed ID: 8362868 [No Abstract] [Full Text] [Related]
77. Implementation of intelligent infusion technology in a multihospital setting. Dusing Wiest M; Longshore L; Harger N Am J Health Syst Pharm; 2010 Jun; 67(11):878-83. PubMed ID: 20484209 [No Abstract] [Full Text] [Related]
78. Letter: Addition of drugs to intravenous fluids. Davis M Med J Aust; 1975 Mar; 1(9):284. PubMed ID: 1128422 [No Abstract] [Full Text] [Related]
79. Hangover and hydration therapy in the time of intravenous drug shortages: an ethical dilemma and a safety concern. Chan LN; Seres DS; Malone A; Holcombe B; Guenter P; Plogsted S; Teitelbaum DH JPEN J Parenter Enteral Nutr; 2014 Nov; 38(8):921-3. PubMed ID: 25342585 [No Abstract] [Full Text] [Related]
80. Letter: Addition of drugs to intravenous fluids. Breckenridge AM; Baker JA Lancet; 1976 May; 1(7969):1127-8. PubMed ID: 57530 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]